Quarterly report pursuant to Section 13 or 15(d)

Note 3 - Acquisitions - Summarize Fair Value of Assets and Liabilities Assumed as of Acquisition Date (Details)

v3.6.0.2
Note 3 - Acquisitions - Summarize Fair Value of Assets and Liabilities Assumed as of Acquisition Date (Details) - USD ($)
$ in Thousands
 5 Months Ended 6 Months Ended
Aug. 01, 2016
Dec. 31, 2016
Dec. 31, 2016
Dec. 31, 2015
Jun. 30, 2016
Goodwill   $ 557,731 $ 557,731   $ 430,882
Goodwill     (1,809)    
Cash paid, net of cash acquired     255,929 $ 82,888  
Long-term contingent consideration payable   28,600 28,600   $ 38,500
Advanced Cell Diagnostics (ACD) [Member]          
Current assets, net of cash $ 25,196 25,196 25,196    
Equipment 2,757 2,757 2,757    
Other long-term assets 3,812 3,812 3,812    
Goodwill 133,780 127,487 127,487    
Goodwill   6,293      
Total assets acquired 366,772 360,479 360,479    
Liabilities 3,591 3,591 3,591    
Deferred income taxes, net 78,761 71,734 71,734    
Deferred income taxes, net   (7,027)      
Net assets acquired 284,393 285,127 285,127    
Cash paid, net of cash acquired 246,193 734 246,927    
Long-term contingent consideration payable 38,200 38,200 38,200    
Advanced Cell Diagnostics (ACD) [Member] | Developed Technology Rights [Member]          
Intangible assets 107,000 107,000 107,000    
Advanced Cell Diagnostics (ACD) [Member] | Trade Names [Member]          
Intangible assets 17,000 17,000 17,000    
Advanced Cell Diagnostics (ACD) [Member] | Customer Relationships [Member]          
Intangible assets 77,000 77,000 77,000    
Advanced Cell Diagnostics (ACD) [Member] | Noncompete Agreements [Member]          
Intangible assets $ 200 $ 200 $ 200